Jefferies Boosts Doximity’s 2024 Growthby Mark Eisenberg 12.02.2024Jefferies raises price target on Doximity Inc. as company expects above-market growth. Analysts express optimism but caution about high valuation ...
Cadence Q4 Earnings: A Miss Ahead? Buy or Sell Now?by Terry Bingman 12.02.2024Cadence has had a weak quarter and predicts underwhelming revenue for the next. Find out if you should buy or ...